Related Experiment Video
Updated: Feb 12, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
Early Clinical Results of Perceval Sutureless Aortic Valve in 139 Patients: Freeman Experience
Syed Saleem Mujtaba1, Simon Ledingham1, Asif Raza Shah1
1Department of Cardiothoracic Surgery, Freeman Hospital, Freeman Road, United Kingdom of Great Britain and Northern Ireland.
Objective:
The aim of this retrospective study is to evaluate the safety and performance of the Perceval sutureless valve in patients undergoing aortic valve replacement. We report the 30-day clinical outcomes of 139 patients.
Methods:
From January 2014 to December 2016, 139 patients underwent sutureless aortic valve replacement. Their operation notes, National Adult Cardiac Surgery Database and perioperative transoesophageal echocardiography findings were studied retrospectively.
Results:
Ninety-two patients underwent isolated aortic valve replacement (group A) with Perceval valve and 47 patients had combined procedures of aortic valve replacement and coronary artery bypass grafting (group B). The patients received a size S (n=23), M (n=39), L (n=42) or XL (n=35) prosthesis. Perceval valve was successfully implanted in 135 (97.1%) patients. Mean cross-clamping time and bypass time were 40 and 63 minutes for isolated cases, while 68 and 107 minutes for combined cases. Three (2.1%) patients died within 30 days. Four patients suffered stroke and 5 patients went into acute renal failure. Median intensive care unit and hospital stay was 2 and 8.5, respectively. Four valves were explanted due to significant paravalvular leak after surgery. Five patients had permanent pacemaker as a result of complete heart block and mean postoperative drainage was 295 mL for isolated case and 457 mL for combined cases. The mean gradient across Perceval valve was 12.5 mmHg while its effective orifice area was 1.5 cm2.
Conclusion:
Early postoperative results showed that Perceval valve is safe. Further follow up is needed to evaluate the long-term outcome with this bioprosthesis.
Insights
The Perceval sutureless valve demonstrates safety in aortic valve replacement, with a 97.1% successful implant rate and low 30-day mortality. Further studies are needed for long-term outcomes.
Area of Science:
- Cardiovascular Surgery
- Bioprosthetic Devices
- Surgical Outcomes
Background:
- Aortic valve replacement is a critical procedure for patients with severe aortic valve disease.
- Sutureless bioprosthetic valves offer potential advantages in reducing cross-clamp and bypass times.
- The Perceval valve is a novel sutureless option for aortic valve replacement.
Purpose of the Study:
- To evaluate the safety and performance of the Perceval sutureless valve in patients undergoing aortic valve replacement.
- To report the 30-day clinical outcomes of patients who received the Perceval valve.
- To assess early complications and hemodynamic performance of the Perceval valve.
Main Methods:
- Retrospective study of 139 patients undergoing aortic valve replacement with the Perceval valve from January 2014 to December 2016.
- Data collected from operation notes, National Adult Cardiac Surgery Database, and perioperative transesophageal echocardiography.
- Patients categorized into isolated aortic valve replacement (n=92) and combined procedures (n=47).
Main Results:
- Successful implantation of the Perceval valve in 97.1% of patients (135/139).
- Low 30-day mortality (2.1%, 3/139), with major complications including stroke (4 patients) and acute renal failure (5 patients).
- Mean gradient of 12.5 mmHg and effective orifice area of 1.5 cm² indicate good hemodynamic function. Four valves were explanted due to paravalvular leak.
Conclusions:
- The Perceval sutureless valve is safe for early postoperative outcomes in aortic valve replacement.
- The valve demonstrates acceptable hemodynamic performance in the early postoperative period.
- Long-term follow-up is necessary to fully ascertain the durability and clinical efficacy of this bioprosthesis.
More Related Videos
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Heart Valves
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
What is an Experiment?
Thomson's e/m Experiment
A particle with charge q, speed v, and mass m enters an area from the top, where the magnetic and electric fields are perpendicular both to the particle's motion and to one another. The magnetic...
Mitral Valve Prolapse I: Introduction
Controls in Experiments

